Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-252456
Abstract: Thromboangiitis obliterans (TAO), also known as Buerger’s disease, is a rare small vessel vasculitis that is associated with an increased risk of arterial occlusion. Although venous thromboembolism has been described, the risk of its recurrence…
read more here.
Keywords:
thromboangiitis obliterans;
chronic management;
pulmonary embolism;
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Vascular Research"
DOI: 10.1159/000512596
Abstract: Data regarding women and thromboangiitis obliterans (TAO) are conflicted, and a few cases of pregnancy have been described. We aimed to describe the interplay between TAO and pregnancies. Among 224 TAO patients, 22.8% were women.…
read more here.
Keywords:
women pregnancy;
pregnancy thromboangiitis;
thromboangiitis obliterans;
thromboangiitis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Vascular and Endovascular Surgery"
DOI: 10.1177/1538574417744085
Abstract: Purpose: When critical limb ischemia (CLI) occurs in patients with thromboangiitis obliterans (TAO) or Buerger’s disease, smoking cessation alone may be insufficient to relieve rest pain and promote wound healing. Accordingly, adjunctive measures are warranted…
read more here.
Keywords:
buerger disease;
patients tao;
tao cli;
treatment ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2022 at "Obstetric Medicine"
DOI: 10.1177/1753495x20980251
Abstract: Thromboangiitis obliterans, also known as Buerger’s disease, is rarely reported in young women in pregnancy. It is an occlusive vascular disorder, characterised by episodic non-atherosclerotic thrombosis of small- and medium-sized blood vessels. Thromboangiitis obliterans predominantly…
read more here.
Keywords:
literature;
report;
case;
thromboangiitis obliterans ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Vascular Health and Risk Management"
DOI: 10.2147/vhrm.s172047
Abstract: Background The possible role of infectious pathogens in the development of thromboangiitis obliterans (TAO) was considered soon after the disease was first described. However, it is not yet known whether infectious pathogens induce thrombotic vasculitis…
read more here.
Keywords:
tao;
phase;
phase tao;
autoimmune flare ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Internal Medicine"
DOI: 10.2169/internalmedicine.3372-19
Abstract: A 48-year-old woman with severe pain and numbness of her right leg and foot was admitted to our hospital. She had never smoked and had little exposure to passive smoking. Initially, polyarteritis nodosa with anti-phospholipid…
read more here.
Keywords:
phospholipid antibodies;
non smoking;
thromboangiitis obliterans;
anti phospholipid ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Current molecular medicine"
DOI: 10.2174/1566524020666201120112828
Abstract: BACKGROUND Studies suggest that cytokines are involved in the development of both inflammatory disorders and vascular diseases. OBJECTIVE The changes in transforming growth factor β (TGFβ), interleukin 6 (IL6), tumor necrosis factor α (TNFα), and…
read more here.
Keywords:
patients different;
analysis;
analysis patients;
thromboangiitis obliterans ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Current vascular pharmacology"
DOI: 10.2174/1570161119666210118125424
Abstract: BACKGROUND Thromboangiitis obliterans (TAO) is a chronic, non-atherosclerotic, progressive inflammatory vascular disease affecting the small- and medium-size arteries and veins of the extremities. OBJECTIVE To evaluate whether long-term anticoagulation with low-molecular-weight heparin (LMWH) and warfarin…
read more here.
Keywords:
low molecular;
obliterans tao;
weight heparin;
molecular weight ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.1018438
Abstract: Baiying Qingmai Formulation (BF) is a classical clinical prescription used for decades to treat thromboangiitis obliterans (TAO). Although it effectively relieves pain and ischemic ulcers in patients with TAO, its anti-TAO mechanisms remain unclear. The…
read more here.
Keywords:
thromboangiitis obliterans;
rage;
hmgb1 rage;
signaling pathways ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.827733
Abstract: Si-Miao-Yong-An-Tang (SMYAT) is a classic prescription for the treatment of thromboangiitis obliterans (TAO). However, the effect and mechanism are still unclear. This experiment aims to evaluate the therapeutic effect and mechanism of SMYAT on sodium…
read more here.
Keywords:
thromboangiitis obliterans;
effect;
effect mechanism;
therapeutic effect ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Surgery"
DOI: 10.3389/fsurg.2022.859201
Abstract: Introduction The chronic ischemic injury of the upper/lower limbs caused by thromboangiitis obliterans (TAO, Buerger's disease) is difficult to heal, leading to high morbidity and amputation risk, seriously lowering the quality of life of patients.…
read more here.
Keywords:
thromboangiitis obliterans;
chronic ischemic;
bone transport;
transport ... See more keywords